about
The promise of neuroprotective agents in Parkinson's diseaseMitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug developmentCreatine for women in pregnancy for neuroprotection of the fetusCreatine for Parkinson's diseaseCreatine for amyotrophic lateral sclerosis/motor neuron diseaseCreatine for women in pregnancy for neuroprotection of the fetusCreatine for Parkinson's diseaseCreatine for amyotrophic lateral sclerosis/motor neuron diseaseThe role of oxidative stress in Parkinson's diseaseThe creatine kinase system and pleiotropic effects of creatineCreatine supplementation with specific view to exercise/sports performance: an updateCreatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?Oxidative Stress-Mediated Skeletal Muscle Degeneration: Molecules, Mechanisms, and TherapiesRole of creatine supplementation in exercise-induced muscle damage: A mini reviewCreatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancyCreatine kinase in ischemic and inflammatory disordersPerformance Enhancing Diets and the PRISE Protocol to Optimize Athletic PerformanceBeneficial effects of a Q-ter based nutritional mixture on functional performance, mitochondrial function, and oxidative stress in ratsCreatine protects against excitoxicity in an in vitro model of neurodegenerationPhosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effectsMyocardial creatine levels do not influence response to acute oxidative stress in isolated perfused heartDiminution of Oxidative Damage to Human Erythrocytes and Lymphocytes by Creatine: Possible Role of Creatine in BloodMitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifyingMetabolic fingerprints in testicular biopsies from type 1 diabetic patients.Understanding the Full Spectrum of Organ Injury Following Intrapartum AsphyxiaDysregulated brain creatine kinase is associated with hearing impairment in mouse models of Huntington diseaseCreatine-induced activation of antioxidative defence in myotube cultures revealed by explorative NMR-based metabonomics and proteomics.The effectiveness of creatine treatment for Parkinson's disease: an updated meta-analysis of randomized controlled trialsSex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in ratsInternational Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicineEffect of creatine, creatinine, and creatine ethyl ester on TLR expression in macrophages.Targeting cellular energy production in neurological disorders.A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosisTherapeutic developments in the treatment of amyotrophic lateral sclerosis.A review of creatine supplementation in age-related diseases: more than a supplement for athletes.Ketogenic diet prevents alterations in brain metabolism in young but not adult rats after traumatic brain injury.Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.Reactive oxygen species in skeletal muscle signaling.No effect of creatine supplementation on oxidative stress and cardiovascular parameters in spontaneously hypertensive rats.Maternal Creatine Supplementation during Pregnancy Prevents Long-Term Changes in Diaphragm Muscle Structure and Function after Birth Asphyxia.
P2860
Q21129436-5E09A98D-F005-4024-9685-A6742E79025AQ22241837-D6E88494-78CE-4738-8879-1161DF20A438Q24187191-1262D014-5161-4E77-9521-710320FBCF09Q24193947-55033461-3D17-47D8-8467-C7088FF15C65Q24202577-82AB1C9D-5BA2-4451-8661-D098FEFC8D01Q24202668-81105E1E-78B4-44B5-B8F1-B8566F2B8770Q24203799-BF4FF6E4-5FF8-4A83-A7E7-A313E9998A90Q24234800-D1D27C11-8A19-4A33-BD15-2CD259C930F9Q24307946-7CA9581B-9B5E-4F52-80DB-BAD820D2B24FQ24609852-26537E3B-8752-49F3-A3B9-0ED52BF84191Q24628688-01C72BCF-6DF3-40B1-8BD4-A8EE90CBE003Q24631151-A60F1FB3-ADAC-463E-8498-2288D7ED0559Q26769962-0593DB62-6E00-4D5F-B00F-5BD3D85447B0Q26780295-2F466429-DD01-49C8-B02A-AC79FA49528AQ27006952-7953E5D0-C05F-44B7-9640-3A326A984B56Q28069271-6EC5169E-FC06-4BDF-8158-D12E1C8880D0Q28080853-366D8D5F-BC59-405B-A668-DDED133CEB48Q28473890-C3C18672-F272-49B7-8256-5F41979ADD02Q28480553-C5C81329-9BD9-478C-AC5A-4A81CE397C31Q28482353-048398B9-6AB9-4A7B-B6F3-57A4F1D45B65Q28543466-A0F1E1B2-BF90-4BDA-89A7-5D7BF6F8CCB9Q28550859-5F839F4B-6C78-4130-B06F-9698BC283862Q28732683-5C227BC1-A1A0-4C32-B539-ED312B77F124Q30375405-11E88F4B-B211-4998-9A7B-B5C79C68982CQ30378459-2E8A1CD6-A6CB-4F33-A2EB-10AD07A97232Q30499300-F5598A70-551C-4E0B-A5B8-9806C6A9A02BQ33657909-7D0F4520-DF4D-4AF2-A3E0-C5781674D9C3Q33760040-49D9B150-EA52-48B0-9A96-09BA8B6DADB3Q33771249-27366439-3FCB-430A-8F28-470FD6CCC646Q33791877-F94C50B9-FB84-415C-B0E6-9C171CACAEFEQ34185252-522B0DC2-7BF0-4900-9C8C-A3BF905BAF74Q34266266-176F8E39-9E97-4892-9C3D-EF3EE8774818Q34610044-61D334DA-13DE-41BD-AABB-43F93482D827Q34974850-3139F70E-FDA5-48FB-BF80-4ADC80A104B1Q35005568-5F523855-C3FF-43E0-83D7-29EB36246DD5Q35212553-E374E1C7-F0C7-4D33-80E6-DE408F03D64BQ35215063-F49D649C-477D-4FA6-92A9-C79F533A532DQ35607438-87548B71-997E-4EB7-958B-22B6D8DBEB85Q35930360-4CC23D41-6522-4B4B-94D7-1647DCCDF80EQ35941493-919EAB24-70E6-484B-9DAD-64FC9BF029F5
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Direct antioxidant properties of creatine.
@en
Direct antioxidant properties of creatine.
@nl
type
label
Direct antioxidant properties of creatine.
@en
Direct antioxidant properties of creatine.
@nl
prefLabel
Direct antioxidant properties of creatine.
@en
Direct antioxidant properties of creatine.
@nl
P2093
P356
P1476
Direct antioxidant properties of creatine.
@en
P2093
John M Lawler
Scott Demaree
William S Barnes
P356
10.1006/BBRC.2001.6164
P407
P577
2002-01-01T00:00:00Z